Pasithea Therapeutics Corp. (NASDAQ: KTTA) Stock Information | RedChip

Pasithea Therapeutics Corp. (NASDAQ: KTTA) Listen to this Section


$4.99
+0.4000 ( +8.72% ) 5.2K

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia.

Market Data


Open


$4.99

Previous close


$4.59

Volume


5.2K

Market cap


$4.85M

Day range


$4.54 - $4.75

52 week range


$4.40 - $17.40

Insider Ownership Transactions

Total Amount Purchased: -59,188.00 | $ -295,348.12

Date Type Amount Purchased Purchaser
2024-06-14 Sale -750.00 Novak Alfred J
2024-03-01 Sale -5938.00 Currie Graeme Martin
2024-03-01 Sale -7500.00 Dumesnil Simon
2024-03-01 Sale -7500.00 Leahy Emer
2024-03-01 Sale -15000.00 Marques Tiago
2024-03-01 Sale -5000.00 Novak Alfred J
2024-03-01 Sale -10000.00 Schneiderman Daniel H
2024-03-01 Sale -7500.00 STEINMAN LAWRENCE

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 67 Aug 13, 2024
8-k 8K-related 14 Jun 26, 2024
4 Insider transactions 1 Jun 14, 2024
def Proxies and info statements 4 May 28, 2024
ars Annual reports 1 May 28, 2024
10-q Quarterly Reports 69 May 14, 2024
8-k 8K-related 14 May 14, 2024
4/a Other 1 Apr 05, 2024
4/a Other 1 Apr 05, 2024
4/a Other 1 Apr 05, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.